LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Analytic Sensitivity of 3 Nucleic Acid Detection Assays in Diagnosis of SARS-CoV-2 Infection.

    Sieker, Jakob T / Horowitz, Coby / Hu, Cheng-Tsung K / Lacombe-Daphnis, Meriane / Chirokas, Bernadette / Pina, Coteia / Heger, Nicholas E / Rabson, Arthur R / Zhou, Ming / Bogen, Steven A / Horowitz, Gary L

    The journal of applied laboratory medicine

    2021  Volume 6, Issue 2, Page(s) 421–428

    Abstract: Background: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse transcription PCR is the primary method to diagnose coronavirus disease 2019 (COVID-19). However, the analytic sensitivity required is not well defined and ... ...

    Abstract Background: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse transcription PCR is the primary method to diagnose coronavirus disease 2019 (COVID-19). However, the analytic sensitivity required is not well defined and it is unclear how available assays compare.
    Methods: For the Abbott RealTime SARS-CoV-2 assay (m2000; Abbott Molecular), we determined that it could detect viral concentrations as low as 26 copies/mL, we defined the relationship between cycle number and viral concentrations, and we tested naso- and oropharyngeal swab specimens from 8538 consecutive individuals. Using the m2000 as a reference assay method, we described the distribution of viral concentrations in these patients. We then used selected clinical specimens to determine the positive percent agreement of 2 other assays with more rapid turnaround times [Cepheid Xpert Xpress (GeneXpert; Cepheid); n = 27] and a laboratory developed test on the Luminex ARIES system [ARIES LDT (Luminex); n = 50] as a function of virus concentrations, from which we projected their false-negative rates in our patient population.
    Results: SARS-CoV-2 was detected in 27% (95% CI: 26%-28%) of all specimens. Estimated viral concentrations were widely distributed, and 17% (95% CI: 16%-19%) of positive individuals had viral concentrations <845 copies/mL. Positive percent agreement was strongly related to viral concentration, and reliable detection (i.e., ≥95%) was observed at concentrations >100 copies/mL for the GeneXpert but not the ARIES LDT, corresponding to projected false-negative rates of 4% (95% CI: 0%-21%) and 27% (95% CI: 11%-46%), respectively.
    Conclusions: Substantial proportions of clinical specimens have low to moderate viral concentrations and may be missed by methods with less analytic sensitivity.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/virology ; COVID-19 Nucleic Acid Testing/instrumentation ; False Negative Reactions ; Female ; Humans ; Limit of Detection ; Male ; Middle Aged ; RNA, Viral/isolation & purification ; Reagent Kits, Diagnostic ; Real-Time Polymerase Chain Reaction/instrumentation ; Reproducibility of Results ; Retrospective Studies ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification
    Chemical Substances RNA, Viral ; Reagent Kits, Diagnostic
    Language English
    Publishing date 2021-03-05
    Publishing country England
    Document type Journal Article
    ISSN 2576-9456
    ISSN 2576-9456
    DOI 10.1093/jalm/jfaa187
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Analytic Sensitivity of Three Nucleic Acid Detection Assays in Diagnosis of SARS-CoV-2 Infection

    Sieker, Jakob T. / Horowitz, Coby / Hu, Cheng-Tsung K. / Lacombe-Daphnis, Meriane / Chirokas, Bernadette / Pina, Coteia / Heger, Nicholas E. / Rabson, Arthur R. / Zhou, Ming / Bogen, Steven A. / Horowitz, Gary L.

    The Journal of Applied Laboratory Medicine

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #857646
    Database COVID19

    Kategorien

  3. Article ; Online: Analytic Sensitivity of Three Nucleic Acid Detection Assays in Diagnosis of SARS-CoV-2 Infection

    Sieker, Jakob T / Horowitz, Coby / Hu, Cheng-Tsung K / Lacombe-Daphnis, Meriane / Chirokas, Bernadette / Pina, Coteia / Heger, Nicholas E / Rabson, Arthur R / Zhou, Ming / Bogen, Steven A / Horowitz, Gary L

    The Journal of Applied Laboratory Medicine ; ISSN 2576-9456 2475-7241

    2020  

    Abstract: Abstract Background Detection of SARS-CoV-2 by reverse transcriptase polymerase chain reaction is the primary method to diagnose Coronavirus Infectious Disease 2019 (COVID-19). Yet, the analytical sensitivity required is not well defined and it is ... ...

    Abstract Abstract Background Detection of SARS-CoV-2 by reverse transcriptase polymerase chain reaction is the primary method to diagnose Coronavirus Infectious Disease 2019 (COVID-19). Yet, the analytical sensitivity required is not well defined and it is unclear how available assays compare. Methods For the Abbott RealTime SARS-CoV-2 assay (Abbott Molecular Inc.; abbreviated as m2000), we determined that it could detect viral concentrations as low as 26 copies/mL, we defined the relationship between cycle number and viral concentrations, and we tested naso- and oropharyngeal swab specimens from N = 8,538 consecutive individuals. Using the m2000 as a reference assay method, we described the distribution of viral concentrations in these patients. We then used selected clinical specimens to determine the positive percent agreement of two other assays with more rapid turnaround times (Cepheid Xpert Xpress (Cepheid Inc.; GeneXpert, N = 27 specimens) and a laboratory developed test on the Luminex ARIES system (Luminex Corporation; ARIES LDT, N = 50)) as a function of virus concentrations, from which we projected their false negative rates in our patient population. Results SARS-CoV-2 was detected in 27% (95% confidence interval of 26-28%) of all specimens. Estimated viral concentrations were widely distributed and 17% (16-19%) of positive individuals had viral concentrations below 845 copies/mL. Positive percent agreement was strongly related to viral concentration and reliable detection (i.e. ≥95%), was observed at concentrations >100 copies/mL for the GeneXpert but not the ARIES LDT, corresponding to projected false negative rates of 4% (0-21%) and 27% (11-46%), respectively. Conclusions Substantial proportions of clinical specimens have low to moderate viral concentrations and may be missed by methods with lesser analytical sensitivity.
    Keywords covid19
    Language English
    Publisher Oxford University Press (OUP)
    Publishing country uk
    Document type Article ; Online
    DOI 10.1093/jalm/jfaa187
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top